Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

In-Hospital Mortality Following Traumatic Brain Injury Among Older Medicare Beneficiaries, Comparing Statin Users With Nonusers.

Khokhar B, Simoni-Wastila L, Slejko JF, Perfetto E, Zhan M, Smith GS.

J Pharm Technol. 2017 Dec;33(6):225-236. doi: 10.1177/8755122517735656. Epub 2017 Oct 12.

2.

The Effectiveness of Pharmacist-Provided Telephonic Medication Therapy Management on Emergency Department Utilization in Home Health Patients.

Gernant SA, Snyder ME, Jaynes H, Sutherland JM, Zillich AJ.

J Pharm Technol. 2016 Oct 1;32(5):179-184. doi: 10.1177/8755122516660376. Epub 2016 Jul 22.

3.

Impact of Laws Regulating Pain Clinics on Opioid Prescribing and Opioid-Related Toxicity Among Texas Medicare Part D Beneficiaries.

Raji MA, Kuo YF, Chen NW, Hasan H, Wilkes DM, Goodwin JS.

J Pharm Technol. 2017 Apr;33(2):60-65. doi: 10.1177/8755122516686226. Epub 2017 Jan 10.

4.

Patterns of Statin Use in Older Medicare Beneficiaries With Traumatic Brain Injury.

Khokhar B, Simoni-Wastila L, Slejko JF, Perfetto E, Zhan M, Smith GS.

J Pharm Technol. 2017;33(4):156-166. doi: 10.1177/8755122517710671. Epub 2017 May 23.

5.

The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.

Keller SC, Ciuffetelli D, Bilker W, Norris A, Timko D, Rosen A, Myers JS, Hines J, Metlay J.

J Pharm Technol. 2013 Oct;29(5):205-214.

6.

Cognitive Impairment and Medication Complexity in Community-Living Older Adults: The Health, Aging and Body Composition Study.

Lee DS, de Rekeneire N, Hanlon JT, Gill TM, Bauer DC, Meibohm B, Harris TB, Jeffery SM.

J Pharm Technol. 2012 Jul 1;28(4):156-162.

7.

Community Pharmacy Use Patterns of Women with HIV and Women At Risk for HIV in the San Francisco Bay Area.

Cocohoba J, Hsu T, Greenblatt RM.

J Pharm Technol. 2010 Sep-Oct;26(5):271-275.

8.

Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure.

Vardeny O, Zebrack J, Gilbert EM, Cheang KI.

J Pharm Technol. 2009;25(2):71-78.

9.

Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic Veterans.

Kim N, Agostini J, Justice A.

J Pharm Technol. 2009 Jul;25(4):223-229.

Supplemental Content

Loading ...
Support Center